Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Luminari

Showing results (111-120 of 210) with videos related to

Pageof 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter StudiesMichel Meignan, Anne Ségolène Cottereau, Annibale Versari, et al.
European Journal of Haematology|August 2, 2006
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosisCarlo Visco, Gianpaolo Nadali, Theodoros P Vassilakopoulos, et al.
Haematologica|November 21, 2007
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL studyMassimo Federico, Cesare Guglielmi, Stefano Luminari, et al.
Frontiers in Oncology|August 3, 2023
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020Lucia Mangone, Domenico Penna, Francesco Marinelli, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 3, 2016
The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)Stephane Chauvie, Fabrizio Bergesio, Federica Fioroni, et al.
Leukemia & Lymphoma|March 23, 2013
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana LinfomiFrancesco Merli, Stefano Luminari, Giuseppe Rossi, et al.
Blood Advances|September 3, 2025
Early clearance of circulating tumor DNA and association with odronextamab response in relapsed/refractory FL and DLBCLJon E Arnason, Matthew J Matasar, Stefano Luminari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma projectMassimo Federico, Thomas Rudiger, Monica Bellei, et al.
Frontiers in Oncology|December 23, 2021
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana LinfomiLaura Ballotta, Pier Luigi Zinzani, Stefano Pileri, et al.
The Lancet. Haematology|April 1, 2016
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studiesJudith Trotman, Stefano Luminari, Sami Boussetta, et al.
Pageof 21

Showing results (111-120 of 210) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter StudiesMichel Meignan, Anne Ségolène Cottereau, Annibale Versari, et al.
European Journal of Haematology|August 2, 2006
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosisCarlo Visco, Gianpaolo Nadali, Theodoros P Vassilakopoulos, et al.
Haematologica|November 21, 2007
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL studyMassimo Federico, Cesare Guglielmi, Stefano Luminari, et al.
Frontiers in Oncology|August 3, 2023
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020Lucia Mangone, Domenico Penna, Francesco Marinelli, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 3, 2016
The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)Stephane Chauvie, Fabrizio Bergesio, Federica Fioroni, et al.
Leukemia & Lymphoma|March 23, 2013
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana LinfomiFrancesco Merli, Stefano Luminari, Giuseppe Rossi, et al.
Blood Advances|September 3, 2025
Early clearance of circulating tumor DNA and association with odronextamab response in relapsed/refractory FL and DLBCLJon E Arnason, Matthew J Matasar, Stefano Luminari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma projectMassimo Federico, Thomas Rudiger, Monica Bellei, et al.
Frontiers in Oncology|December 23, 2021
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana LinfomiLaura Ballotta, Pier Luigi Zinzani, Stefano Pileri, et al.
The Lancet. Haematology|April 1, 2016
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studiesJudith Trotman, Stefano Luminari, Sami Boussetta, et al.
Pageof 21